SCHEMBL12283785

SCHEMBL12283785

CC(C)(C)OC(=O)N[C@H]1CCN(c2c(Br)cccc2C=O)C1

nearest known ligand 0.52

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 1/20 0.52
▸ PIM3 Q86V86 1/20 0.52
▸ PIM2 Q9P1W9 1/20 0.52
▸ SUV39H2 Q9H5I1 3/20 0.45
▸ CTSK P43235 2/20 0.44
▸ CKS1B P61024 1/20 0.43
▸ SKP1 P63208 1/20 0.43
▸ SKP2 Q13309 1/20 0.43
▸ PDE10A Q9Y233 1/20 0.43
▸ MAP4K4 O95819 2/20 0.42
▸ KMT2A Q03164 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ PARP1 P09874 1/20 0.41
▸ DRD2 P14416 2/20 0.40
▸ KCNA3 P22001 1/20 0.40
▸ BRD4 O60885 2/20 0.40
▸ DRD3 P35462 1/20 0.39
▸ KDM4D Q6B0I6 1/20 0.39
▸ BTK Q06187 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12283721 0.94 MAP4K4 (0.49) PIM1PIM3PIM2SUV39H2CTSK
SCHEMBL2425209 0.94 MAP4K4 (0.49) PIM1PIM3PIM2SUV39H2CTSK
SCHEMBL13537761 0.88 PIM1 (0.53) PIM1PIM3PIM2SUV39H2CTSK
SCHEMBL12283734 0.88 PIM1 (0.52) PIM1PIM3PIM2SUV39H2CTSK
SCHEMBL30079320 0.88 PIM1 (0.52) PIM1PIM3PIM2CTSKCKS1B
SCHEMBL12283853 0.88 PIM1 (0.52) PIM1PIM3PIM2SUV39H2CTSK
SCHEMBL12284134 0.87 PIM1 (0.52) PIM1PIM3PIM2SUV39H2CTSK
SCHEMBL21248793 0.84 PIM1 (0.45) PIM1PIM3PIM2SUV39H2CTSK
SCHEMBL21248794 0.84 PIM1 (0.45) PIM1PIM3PIM2SUV39H2CTSK
SCHEMBL12284452 0.84 PIM1 (0.49) PIM1PIM3PIM2SUV39H2CTSK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-20150051185-A1 Chemical Compounds 251 ASTRAZENECA AB (SE) 2015-02-19 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-8901307-B2 Chemical compounds 251 ASTRAZENECA AB (SE) 2014-12-02 — — US disclosed
US-20110218182-A1 CHEMICAL COMPOUNDS 251 ASTRAZENECA AB (SE) 2011-09-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110218182-A1 CHEMICAL COMPOUNDS 251 PIM1, PIM3, PIM2 PIM1 1/4885PIM3 2/4885PIM2 3/4885
US-20150051185-A1 Chemical Compounds 251 PIM1, PIM3, PIM2 PIM1 1/4885PIM3 2/4885PIM2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback